Research Articles | Page 4 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Pro-inflammatory proteins S100A9 and TNFα suppress erythropoietin elaboration in myelodysplastic syndromes Oct 2017 Haematologica myelodysplastic syndromes (MDS)
SOHO State of the Art Update and Next Questions: Biology and Treatment of Myelodysplastic Syndromes Oct 2017 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Gemtuzumab Receives New FDA Approval for Acute Myeloid Leukemia Sep 2017 NIHNCI acute myeloid leukemia (AML)
Hypomethylating agents in myelodysplastic syndromes and population-level outcomes: a changing landscape or a small dent? Sep 2017 Leuk Lymphoma myelodysplastic syndromes (MDS)
Clinical trial reveals genetic fault that reduces the effectiveness of leukemia treatment Sep 2017 Science Codex acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia Sep 2017 Exp Hematol aplastic anemia
Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia Sep 2017 Exp Hematol aplastic anemia
Characterization of TP53 Mutations in Low-Grade Myelodysplastic Syndromes and Myelodysplastic Syndromes with a Non-Complex Karyotype Sep 2017 Eur J Haematol myelodysplastic syndromes (MDS)
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)